Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510675 · ClinicalTrials.gov registry record · NA
Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT
A NA study, sponsored by Omeza.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT04510675 is a NA study that has completed, run by Omeza. The registered enrollment target is 58 participants.
The verdict
NCT04510675, a NA study, has completed, sponsored by Omeza.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The primary objective of this study was to assess the sensitization potential of Omeza Collagen Matrix compared to that of a negative control based on a Modified Human Repeat Insult Patch Test.
Interventions
- OTHER Negative Control
- DEVICE Test Article
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2020-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04510675
The ClinicalTrials.gov registry entry for NCT04510675 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Omeza, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Negative Control is the first listed.
NCT04510675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04510675 about?
NCT04510675 is a clinical study titled "Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT". The primary objective of this study was to assess the sensitization potential of Omeza Collagen Matrix compared to that of a negative control based on a Modified Human Repeat Insult Patch Test.
What is the current status of trial NCT04510675?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2019-12-02. Estimated completion is 2020-01-11.
What interventions are being tested in trial NCT04510675?
The interventions under investigation include: Negative Control (OTHER), Test Article (DEVICE).
Who is sponsoring clinical trial NCT04510675?
This trial is sponsored by Omeza, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.